31
Participants
Start Date
September 22, 2011
Primary Completion Date
September 5, 2018
Study Completion Date
September 5, 2018
Ruxolitinib
15 mg by mouth twice daily (BID), continuously in 28-day cycles.
Lenalidomide
5 mg by mouth each day on days 1-21, followed by 7 days of no therapy of each 28 day cycle.
Prednisone
"Prednisone will be added for patients who have not responded after 3 cycles of therapy.~30 mg by mouth a day during cycle 4, 15 mg/day during cycle 5, and 15 mg every other day during cycle 6, and then it will be discontinued."
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Incyte Corporation
INDUSTRY
M.D. Anderson Cancer Center
OTHER